Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Life Sciences Greenhouse Investments (LSGI) is an evergreen venture fund established in 2002 through legislation that allocated funds from the Master Tobacco Settlement Act. Based in Harrisburg, Pennsylvania, LSGI aims to enhance the life sciences ecosystem in the state while improving healthcare outcomes globally. The fund has a total capital of $44 million and has invested in 86 companies, creating and retaining over 1,850 jobs in Pennsylvania.
LSGI provides early-stage capital and operational expertise to life science companies, focusing on drug discovery, diagnostics, and medical devices. The organization has successfully attracted $773 million in follow-on funding for its portfolio companies, indicating a strong impact on the local economy and the life sciences sector.
LSGI invests in early-stage life science companies, particularly those involved in drug discovery, diagnostics, and medical devices. The fund bridges the funding gap between pre-seed and Series B stages, offering investments ranging from $250,000 to $1.5 million. LSGI emphasizes the importance of operational support and scientific advice to help companies commercialize their innovative healthcare solutions effectively.
The organization seeks to partner with startups that have the potential to significantly impact human health. LSGI's investment strategy is designed to strengthen the life sciences ecosystem in Pennsylvania while improving healthcare outcomes on a global scale. The firm values companies that demonstrate a clear path to commercialization and have innovative approaches to addressing healthcare challenges.
LSGI has invested $44 million across 86 companies, contributing to advancements in the life sciences sector. Notable portfolio companies include:
These companies have collectively created and retained over 1,850 direct and indirect jobs in Pennsylvania and have attracted $773 million in follow-on funding, showcasing the fund's significant impact on the local economy.
Fred Marroni - President & CEO of Indigo Biosciences, brings extensive experience in the life sciences sector and has been instrumental in guiding LSGI's investment strategy.
Christopher P. Molineaux - President & CEO of Life Sciences Pennsylvania, contributes significant expertise in the regional life sciences landscape and helps align LSGI's goals with broader industry trends.
Kelly Wylam - Executive Director of Innovation Partnership (iPart), focuses on fostering innovation and collaboration within the life sciences community.
Lance M. Westerhoff, Ph.D. - President and General Manager of QuantumBio Inc., offers deep scientific knowledge and operational experience in the biotech field.
Wayne Barz - Chief Investment Officer at Ben Franklin Technology Partners of Northeast PA, provides insights into investment strategies and economic development initiatives.
To pitch Life Sciences Greenhouse Investments, founders should use the contact form available at lsgpa.com/contact or email admin@LSGPA.com. It is important to include a comprehensive deck that outlines the business model, team, and product details. LSGI typically reviews pitches promptly, and warm introductions can enhance the chances of a successful engagement.
In March 2024, LSGI announced that SIRPant Immunotherapeutics had dosed its first patient in a Phase 1 clinical trial, marking a significant milestone for the company.
In September 2023, LSGI participated in an oversubscribed SAFE round for Ilico Genetics, which developed a groundbreaking stomach-cancer detection test.
Additionally, in March 2024, INDIGO Biosciences released a family of cell-based reporter assays, further showcasing the innovative work being done by LSGI's portfolio companies.
What are the investment criteria for LSGI?
LSGI focuses on early-stage life science companies involved in drug discovery, diagnostics, and medical devices. The fund typically invests between $250,000 and $1.5 million, aiming to bridge the funding gap between pre-seed and Series B stages.
How can I apply or pitch to LSGI?
Founders can pitch to LSGI through their website at lsgpa.com/contact or by emailing admin@LSGPA.com. It is advisable to include a detailed business plan and information about the team and product.
What makes LSGI different from other venture funds?
LSGI not only provides capital but also offers operational support and scientific expertise to help portfolio companies navigate the complexities of the life sciences sector. This dual approach enhances the likelihood of successful commercialization.
What is LSGI's geographic focus?
LSGI primarily invests in companies based in Pennsylvania, aligning with its mission to strengthen the local life sciences ecosystem while also improving healthcare outcomes globally.
What is the fund size and check size range?
LSGI has a total fund size of $44 million and typically invests between $250,000 and $1.5 million in each company.
What kind of post-investment involvement does LSGI have?
LSGI is actively involved with its portfolio companies, providing ongoing operational support and strategic guidance to help them achieve their commercialization goals.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.